microarray

(redirected from Microarray analysis)
Also found in: Dictionary, Medical.
Related to Microarray analysis: Microarray technology, DNA microarrays, CDNA microarray

microarray

A technique for performing many DNA experiments in parallel. Nothing to do with computers.
References in periodicals archive ?
Microarray Analysis Market Research Report - Global Forecast till 2023, Half-Cooked Research Reports Published by MRFR.
Microarray analysis of p-anisaldehyde-induced transcriptome of Saccharomyces cerevisiae.
To identify the differentially expressed microRNAs in the blood serum between controls and ONIHL subjects, microarray analysis was utilized.
Gene Expression Microarray Analysis. Gene expression profiling of the SCEC and noncancerous tissues was carried out with the Affymetrix HG U133 Plus 2.0 Array (Affymetrix, Santa Clara, CA).
Selection for validated miRNAs was done according to the following criteria: (i) miRNAs, the raw signal for each sample in the miRNA microarray analysis was >50 and was differentially up- or down-regulated in samples from the RIF group compared with the control group; and (ii) miRNAs that were in the core mRNA-miRNA network results.
Validation of the microarray analysis results in the dependent and independent cohorts of human knee cartilage samples was carried out using real-time quantitative PCR (qRT-PCR) analysis.
Microarray analysis is the first-line test for dysmorphism and/or developmental delay in the genetics laboratory, but other techniques can be useful in addition to this method depending upon the clinical features of the patient and the type of abnormality detected.
These experts discuss the practical clinical implications of new society recommendations for antenatal steroid administration, low-dose aspirin for preeclampsia prevention, chromosomal microarray analysis, and Zika virus infection and pregnancy
Microarray Analysis. A DNA microarray analysis was performed using custom-made 16 K MZH chips (GPL14379), as described previously [19].
Genome-wide chromosomal microarray analysis (CMA) to detect copy number variants (CNVs) is generally the first line of testing for patients with unexplained epilepsy with co-morbid neurodevelopmental features.
Moreover, when stillbirth happens, a complete postmortem evaluation that includes autopsy, placental pathology, karyo-type or microarray analysis, and fetal-maternal hemorrhage testing is recommended (Obstet Gynecol.